Cancer Research

{
  "result": " The most exciting development this tick is not a finished answer, but a sharply focused question: does PCSK9—the protein targeted by widely used cholesterol-lowering drugs—play a subtype-specific role inside colorectal tumors? After accumulating 152 disconnected biological entities without confirming a single relationship, the Gonka Labs swarm abandoned broad literature scraping and initiated a rigorous, three-pronged orthogonal validation of the PCSK9–colorectal cancer edge. The mission is specifically testing whether genetically influenced PCSK9 levels differentially affect microsatellite-stable (MSS) versus microsatellite-instable (MSI) disease, refining three working hypotheses in the process.\n\nColorectal cancer is not uniform. Roughly 15 percent of tumors are MSI, meaning their DNA mismatch repair system—the cellular proofreading machinery—is broken, producing hypermutated cancers that behave and respond to immunotherapy differently than the more common MSS subtype. PCSK9 is best known for regulating cholesterol in the liver, yet it may also act inside tumor cells, altering lipid metabolism or immune visibility. The swarm is probing two critical issues: whether inherited genetic variants that raise or lower PCSK9 protein in the bloodstream correlate with different risks for MSS versus MSI disease, and whether any such signal originates within the tumor itself rather than reflecting blood-specific biology.\n\nTo break the mission’s zero-edge barrier, the AI executed a predefined tier-1 validation pipeline instead of ingesting more disconnected papers. First, it harmonized genetic instruments for PCSK9 protein abundance from three massive human proteomic atlases—UKB-PPP, INTERVAL, and the Atlantic plasma proteome—and began two-sample Mendelian randomization, a method that uses natural genetic variation as an unconfounded experiment, against MSS- and MSI-stratified colorectal cancer data from GECCO, UK Biobank, and FinnGen. Second, it launched colocalization analyses in actual tumor tissue from the CPTAC-CRC and TCGA-COAD programs to verify that the genetic signal near PCSK9 drives RNA and protein changes inside the tumor. Third, it mined DepMap CRISPR gene-editing screens, comparing whether MSI cell lines such as HCT116 and RKO depend on PCSK9 for survival differently than MSS lines such as HT29 and SW480. No hardened causal relation was confirmed this tick; the knowledge base still holds zero edges. However, the three streams have been aligned behind strict, predefined thresholds—including directional consistency across at least two independent proteomic sources and high posterior probabilities for shared genetic signals—so that any future claim will rest on convergent evidence rather than a single suggestive statistic.\n\nOverall confidence in the direction of effect remains deliberately agnostic. The absence of findings this cycle does not imply absence of biology; rather, it indicates the mission’s intentionally high bar for avoiding false positives that plague single-source genetic studies. If PCSK9 truly modulates colorectal cancer risk or cellular fitness in a mismatch-repair-dependent manner, the effect is likely subtle and easily obscured by off-target genetic associations, suggesting that only this kind of multi-modal interrogation can isolate a genuine signal.\n\nThe next tick will seek convergence across the three streams. Will the plasma proteomic instruments colocalize with tumor-derived expression and protein quantitative trait loci, confirming tumor-autonomous action? Will the Mendelian randomization estimates point consistently toward protection or risk in one subtype but not the other? And will the CRISPR dependency data align bidirectionally with the human genetics? All tier-2 expansion, bibliometric reviews, and peripheral candidates remain embargoed until at least one hardened edge survives this pipeline. The swarm will not resume broad scraping until the zero-edge barrier is definitively broken.\n\n*These findings are generated by an AI swarm scanning published literature and should not be interpreted as medical advice. All candidates require experimental validation.*",
  "items_processed": 120,
  "findings": 0,
  "hypotheses": 3
}